HQ SPECLT PHARMA RX
FDA Approved Drugs
HQ SPECLT PHARMA RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 11
- Latest Approval Date Jul 23, 2009
- Data Source FDA
- First Approval Date Apr 15, 1993
Company Snapshot
FDA Approved Drug Records ( 11 records )
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
16 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
11 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
AMPICILLIN AND SULBACTAM
Application Number
65176
Product Number
1
Active Ingredient
AMPICILLIN SODIUM; SULBACTAM SODIUM
Dosage Form
-
Strength
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.